UBS AM’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Buy |
781,800
+349,459
| +81% | +$923K | ﹤0.01% | 2123 |
|
|
2025
Q1 | $1.3M | Buy |
432,341
+170,607
| +65% | +$514K | ﹤0.01% | 2196 |
|
|
2024
Q4 | $670K | Sell |
261,734
-1,283,068
| -83% | -$3.28M | ﹤0.01% | 2500 |
|
|
2024
Q3 | $5.75M | Sell |
1,544,802
-33,025
| -2% | -$123K | ﹤0.01% | 1490 |
|
|
2024
Q2 | $9.97M | Buy |
1,577,827
+1,394,897
| +763% | +$8.82M | ﹤0.01% | 1140 |
|
|
2024
Q1 | $982K | Hold |
182,930
| – | – | ﹤0.01% | 2025 |
|
|
2023
Q4 | $918K | Hold |
182,930
| – | – | ﹤0.01% | 2072 |
|
|
2023
Q3 | $309K | Hold |
182,930
| – | – | ﹤0.01% | 2425 |
|
|
2023
Q2 | $333K | Hold |
182,930
| – | – | ﹤0.01% | 2444 |
|
|
2023
Q1 | $333K | Buy |
182,930
+35,732
| +24% | +$65K | ﹤0.01% | 2444 |
|
|
2022
Q4 | $746K | Buy |
147,198
+11,843
| +9% | +$60K | ﹤0.01% | 2000 |
|
|
2022
Q3 | $673K | Sell |
135,355
-18,682
| -12% | -$92.9K | ﹤0.01% | 2193 |
|
|
2022
Q2 | $573K | Buy |
154,037
+53,176
| +53% | +$198K | ﹤0.01% | 2255 |
|
|
2022
Q1 | $566K | Hold |
100,861
| – | – | ﹤0.01% | 2422 |
|
|
2021
Q4 | $613K | Buy |
100,861
+57,722
| +134% | +$351K | ﹤0.01% | 2464 |
|
|
2021
Q3 | $420K | Buy |
43,139
+17,217
| +66% | +$168K | ﹤0.01% | 2554 |
|
|
2021
Q2 | $370K | Buy |
25,922
+4,222
| +19% | +$60.3K | ﹤0.01% | 2606 |
|
|
2021
Q1 | $515K | Buy |
21,700
+9,500
| +78% | +$226K | ﹤0.01% | 2378 |
|
|
2020
Q4 | $163K | Buy |
+12,200
| New | +$163K | ﹤0.01% | 2524 |
|
|
2016
Q4 | – | Sell |
-17,700
| Closed | -$138K | – | 2566 |
|
|
2016
Q3 | $138K | Hold |
17,700
| – | – | ﹤0.01% | 2530 |
|
|
2016
Q2 | $110K | Buy |
+17,700
| New | +$110K | ﹤0.01% | 2572 |
|
|
2015
Q4 | – | Sell |
-119,221
| Closed | -$1.37M | – | 2705 |
|
|
2015
Q3 | $1.37M | Buy |
+119,221
| New | +$1.37M | ﹤0.01% | 1595 |
|